Nkarta logo

Nkarta Share Price Today

(NASDAQ: NKTX)

Nkarta share price is $1.64 & ₹142.63 as on 6 Mar 2025, 2.30 'hrs' IST

$1.64

-0.01

(-0.61%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Nkarta share price in Dollar and Rupees. Guide to invest in Nkarta stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Nkarta, along with analyst recommendations, forecasts, and comprehensive financials.

Nkarta share price movements

  • Today's Low: $1.57
    Today's High: $1.67

    Day's Volatility :5.98%

  • 52 Weeks Low: $1.57
    52 Weeks High: $16.24

    52 Weeks Volatility :90.33%

Nkarta (NKTX) Returns

PeriodNkarta IncSector (Health Care)Index (Russel 2000)
3 Months
-37.88%
3.7%
0.0%
6 Months
-69.8%
-2.8%
0.0%
1 Year
-89.56%
2.5%
0.0%
3 Years
-83.08%
12.9%
-11.6%

Nkarta (NKTX) Key Statistics

in dollars & INR

Previous Close
$1.65
Open
$1.65
Today's High
$1.67
Today's Low
$1.5701
Market Capitalization
$116.4M
Today's Volume
$1.2M
52 Week High
$16.24
52 Week Low
$1.57
Revenue TTM
$385.0
EBITDA
$-118.1M
Earnings Per Share (EPS)
$-1.85
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-30.4%

How to invest in Nkarta Stock (NKTX) from India?

It is very easy for Indian residents to invest directly in Nkarta from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Nkarta stock in both Indian Rupees (INR) and US Dollars (USD). Search for Nkarta or NKTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Nkarta or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Nkarta shares which would translate to 0.530 fractional shares of Nkarta as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Nkarta, in just a few clicks!

Returns in Nkarta (NKTX) for Indian investors in Rupees

The Nkarta stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Nkarta investment value today

Current value as on today

₹15,388

Returns

₹84,612

(-84.61%)

Returns from Nkarta Stock

₹89,561 (-89.56%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Nkarta (NKTX)

14%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Nkarta Stock from India on INDmoney has increased by 14% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Nkarta

  • RA Capital Management, LLC

    15.31%

  • BlackRock Inc

    6.59%

  • Boxer Capital LLC

    5.71%

  • Samsara BioCapital, LLC

    5.34%

  • NEA Management Company, LLC

    5.06%

  • Citadel Advisors Llc

    5.05%

Analyst Recommendation on Nkarta

Buy

    93%Buy

    6%Hold

    0%Sell

Based on 16 Wall street analysts offering stock ratings for Nkarta(by analysts ranked 0 to 5 stars)

Based on 16 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
15
15
15
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Nkarta Stock (NKTX)

What analysts predicted

Upside of 784.15%

Target:

$14.50

Current:

$1.64

Insights on Nkarta Stock (Ticker Symbol: NKTX)

  • Price Movement

    In the last 1 month, NKTX stock has moved down by -29.9%
  • NKTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 156.1%
  • NKTX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 133.6%

Nkarta Technicals Summary

Sell

Neutral

Buy

Nkarta is currently in a neutral trading position according to technical analysis indicators.

Nkarta (NKTX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Nkarta Inc logo
-27.43%
-69.8%
-89.56%
-83.08%
-96.58%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Nkarta Inc logo
NA
NA
NA
-1.67
-0.3
-0.17
NA
6.11
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Nkarta Inc logo
Buy
$116.4M
-96.58%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Nkarta

Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. The company's lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen that is in Phase 1 clinical trial for the treatment of relapsed/refractory (r/r) non-hodgkin lymphoma, as well as for lupus nephritis. It also develops NKX101, a CAR NK product candidate targeting cells that display NKG2D ligands, which is in Phase I clinical trial for the treatment of r/r acute myeloid leukemia or higher risk myelodysplastic syndromes, as well as for solid tumors. In addition, the company develops NKX070, targeting the CD70 tumor antigen to treat solid and liquid tumors; and NK+T cell therapy for use in the treatment of oncology, autoimmune disease, or infectious disease. It has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.
Organization
Nkarta
Employees
159
CEO
Mr. Paul J. Hastings
Industry
Health Technology

Management People of Nkarta

NameTitle
Mr. Paul J. Hastings
CEO & Director
Ms. Alyssa Levin C.A., CPA
Chief Financial & Business Officer and Principal Accounting Officer
Dr. Nadir Mahmood Ph.D.
President
Dr. Ralph Brandenberger Ph.D.
Chief Technical Officer
Mr. Greg Mann
Vice President of Public Affairs and Investor Relations
Dr. Alicia J. Hager
Chief Legal Officer & Corporate Secretary

Important FAQs about investing in NKTX Stock from India :

What is Nkarta share price today?

Nkarta share price today stands at $1.64, Open: $1.65 ; Previous Close: $1.65 ; High: $1.67 ; Low: $1.57 ; 52 Week High: $16.24 ; 52 Week Low: $1.57.

The stock opens at $1.65, after a previous close of $1.65. The stock reached a daily high of $1.67 and a low of $1.57, with a 52-week high of $16.24 and a 52-week low of $1.57.

Can Indians buy Nkarta shares?

Yes, Indians can invest in the Nkarta (NKTX) from India.

With INDmoney, you can buy Nkarta at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Nkarta at zero transaction cost.

How can I buy Nkarta shares from India?

It is very easy to buy Nkarta from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Nkarta (NKTX) be purchased?

Yes, you can buy fractional shares of Nkarta with INDmoney app.

What are the documents required to start investing in Nkarta stocks?

To start investing in Nkarta, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Nkarta Stock (NKTX)?

Today’s highest price of Nkarta (NKTX) is $1.67.

Today’s lowest price of Nkarta (NKTX) is $1.57.

What is today's market capitalisation of Nkarta?

Today's market capitalisation of Nkarta NKTX is 116.4M

What is the 52 Week High and Low Range of Nkarta Stock (NKTX)?

  • 52 Week High

    $16.24

  • 52 Week Low

    $1.57

What are the historical returns of Nkarta (NKTX)?

  • 1 Month Returns

    -27.43%

  • 3 Months Returns

    -69.8%

  • 1 Year Returns

    -89.56%

  • 5 Years Returns

    -96.58%

Who is the Chief Executive Officer (CEO) of Nkarta ?

Mr. Paul J. Hastings is the current Chief Executive Officer (CEO) of Nkarta.